Everfront Biotech Inc.- Rising Star in Pharmaceutical Innovation

EFB is committed to fulfilling unmet medical needs
by developing orphan drugs to treat the world’s most lethal diseases including high grade glioma and pancreatic cancer
Brain Tumor (Glioblastoma, GBM) and Pancreatic Cancer (PC)
Everfront Biotech Inc. Receives "Investor's Choice Award" at the 2023 NBRP Demo Day Investment Matchmaking Competition
EFB'S Mission
EFB’s Mission

EFB is committed to fulfilling unmet medical needs

Rising Star in Pharmaceutical Innovation
Rising Star in Pharmaceutical Innovation

EFB is committed to fulfilling unmet medical needs by developing orphan drugs to treat the world’s most lethal diseases.

Curing Rare Cancer
Curing Rare Cancers

Including
Glioblastoma (GBM) and
Pancreatic cancer (PC)

Latest News
Investor's Choice Award

Everfront Biotech Inc. Receives "Investor's Choice Award" at the 2023 NBRP Demo Day Investment Matchmaking Competition

previous arrow
next arrow

PRODUCT HIGHLIGHTS of Cerebraca® Wafer

A Biodegradable Implant Targeting GBM with One-month Sustained Drug Release

Latest News

Explore Everfront Biotech

Our Company

A look inside EFB

Learn more >

Video Room

Featured video about EFB

See all videos >

Scientific Publications

Academic papers published by our team

See all publications>

We want to hear from you.

Contact us

Development Pipeline

Pepline - EF-001